Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
BRAF V600E
Beijing, Beijing Municipality
BRAF V600E Clinical Trials in Beijing, Beijing Municipality
1 recruiting
Beijing, Beijing Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
BRAF V600E
Tianjin Medical University Cancer Institute and Hospital
49 enrolled
4 locations
NCT07506109
Feedback